Australia's MedAdvisor rises to 3-wk high on higher app uptake in U.S.

Adheris Health

29/11/2022 04:55

** Shares of healthcare app firm MedAdvisor  MDR.AX  rise as
much as 10.5% to A$0.21, their highest level since Nov. 8
    ** Co says it expects a larger-than-usual seasonal uptick in
the use of its U.S.-based digital platform inMotion due to
ongoing flu season 
    ** Says increased platform use has positively impacted Q1
results, with further effect expected to be felt in Q2 
    ** MDR down 51.9% YTD, as of last close
 (Reporting by Harshita Swaminathan)
 ((Harshita.Swaminathan@thomsonreuters.com))